Indoleamine 2,3-dioxygenase activity during I131-radioisotope therapy for metastatic thyroid cancer

Kenichi Sakurai, Shigeru Fujisaki, Keita Adachi, Shuhel Suzuki, Yuki Masuo, Saki Nagashima, Yukiko Hara, Ryouichi Tomita, Kenji Gonda, Tomohiro Hirano, Katsuhisa Enomoto

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Indoleamine 2,3-dioxygenase activity during I131-radioisotope therapy for metastatic thyroid cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science